Very proud to share this 7-years adventure: Lung cancer on chip to approach a predictive tool for immunotherapy in a patient-derived ex-vivo reconstitued lung cancer miroenvironment ⁦Institut Curie⁩ ⁦Institut du Cancer AP-HP. Nord⁩ ⁦Hôpital Bichat - Claude-Bernard AP-HP⁩ ⁦Cell Press⁩

RA-UIP may be due to a cause–effect relationship between UIP and RA, rather than due to a coincidental occurrence of IPF in patients with RA
Thanks Olivia leavy, Leticia Kawano-Dourado Louise V Wain Gisli Jenkins Bruno Crestani Joshua Solomon, MD Raphael Borie 👇
thorax.bmj.com/content/early/…

Have you heard about non-amyloid light chain deposition disease in the lung ? A rare form of cystic/bronchiectatic lung disease. See the study by the OrphaLung network
rdcu.be/dEpjk

Systemic lupus erythematosus: Adding another piece to the connective tissue disease‐associated interstitial lung disease puzzle - Khor - Respirology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/re…

🌏Respirology
Chronic #ILD associated with systemic lupus erythematosus: A multicentric study of 89 cases published in #Respirology

#OpenAccess
onlinelibrary.wiley.com/doi/10.1111/re…
@raphaelborie

Proud to be part of this collaborative work led by Raphael Borie and Vincent Cottin on 'Chronic Interstitial Lung Disease Associated with Systemic Lupus Erythematosus,' published in Respirology.
onlinelibrary.wiley.com/doi/10.1111/re…

This is 🌟ESSENTIAL🌟 reading for all Pulmonary and Critical Care trainees and anyone interpreting chest imaging 🫁

New Fleischner Society Glossary of Terms for Thoracic Imaging in Radiology #OpenAccess #MedEd
Kudos Dr. Alex Bankier & Team! 👏

pubs.rsna.org/doi/10.1148/ra…

Respiratory Medicine and Research recently published a study titled 'Anti-mutated citrullinated vimentin antibodies are increased in IPF patients' Société de Pneumologie de Langue Française (SPLF) Vincent Cottin RespiFIL 🫁 Bruno Crestani Raphael Borie
sciencedirect.com/science/articl…

Interested in rare lung diseases? Join us for the virtual ERS school January the 30th! Registration via link: ersnet.org/events/virtual…

Le PHRC national ERASE-PH COPD est lancé avec le 1er centre ouvert sur Hôpital Bicêtre AP-HP avant un déploiement dans le réseau français Pulmotension
Ce PHRC est destiné a évaluer l'efficacité du tadalafil versus placebo dans l'HTP sévère de la BPCO
RespiFIL 🫁 Société de Pneumologie de Langue Française (SPLF)

I am beyond excited to share the main project of my PhD Casanova Lab which is now
out Cell (doi.org/10.1016/j.cell…). We describe how human CCR2 deficiency leads to impaired monocyte recruitment to the lung, resulting in pulmonary alveolar proteinosis.

Shortened TL is associated with ILD in patients with RA & with baseline disease severity. Congrats Tracy Doyle, Joyce Lee, Jeffrey Sparks MD MMSc, PA Juge & all co-authors 👇

thorax.bmj.com/content/early/…

The survey has been translated into multiple languages:
🇫🇷 French: survey.ucalgary.ca/jfe/form/SV_bB…
🇪🇸 Spanish: survey.ucalgary.ca/jfe/form/SV_8p…
🇳🇱 Dutch: survey.ucalgary.ca/jfe/form/SV_4V…

NEW Position Paper: HRCT phenotypes in Pulmonary #Sarcoidosis : a multinational Delphi consensus study The Lancet Respiratory Medicine

✅Consensus that distinct CT phenotypes exist
✅7 CT phenotypes fibrotic & non-fibrotic

Free download (for 50 days) with this link👇
authors.elsevier.com/c/1iFuY7tFB1Tt…

🎦 Vous avez manqué les webinaires des #PID chez l’adulte et l’enfant, qui se sont tenus en direct les 23 et 28/11❓
Ils sont désormais disponibles en replay
👉bitly.ws/34wax

🕵️Laissez-nous votre avis : bitly.ws/34vW4
🙏Vincent Cottin Société de Pneumologie de Langue Française (SPLF)

[Quoi de neuf, docteur ?]
La journée annuelle de la Plateforme maladies rares Paris Nord commence. Vous pouvez suivre le déroulé de la journée dans ce fil 🧶 ⤵️

Bonne nouvelle de la fin 2023, mieux que le black friday...s'inscrire à la SPLF n'aura jamais été aussi simple..et pas cher...splf.fr/inscription/
un formulaire, 25 ou 50€ et hop, dans la communauté!

🆕Great study by Sabrina Sidali-Proust ‼️
132 patients with telomere-related genes (TRG) mutations vs. 1190 controls:
➡️ among patients: PSVD 48%, cirrhosis 15% ⚠️
➡️5-yr OLT-free survival 🟰 69%
➡️TRG mutations: strong risk factor for liver disease

DOI: 10.1097/HEP.0000000000000667